EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 93 filers reported holding EIDOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $41,520,000 | +160.4% | 315,550 | 0.0% | 5.42% | +73.9% |
Q3 2020 | $15,945,000 | +9.0% | 315,550 | 0.0% | 3.12% | +5.5% |
Q2 2020 | $14,634,000 | -5.3% | 315,550 | 0.0% | 2.96% | -27.9% |
Q1 2020 | $15,459,000 | -14.6% | 315,550 | 0.0% | 4.10% | +15.3% |
Q4 2019 | $18,109,000 | +64.8% | 315,550 | +3.3% | 3.55% | -10.6% |
Q3 2019 | $10,991,000 | +15.7% | 305,550 | 0.0% | 3.97% | +37.3% |
Q2 2019 | $9,496,000 | +102.5% | 305,550 | +52.8% | 2.89% | +122.8% |
Q1 2019 | $4,690,000 | +143.5% | 200,000 | +42.9% | 1.30% | +80.7% |
Q4 2018 | $1,926,000 | – | 140,000 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |